Home
Services
In Vitro Transcribed mRNA Services
LNP Formulated RNA Production Service

LNP Formulated RNA Production Service

mRNA has shown therapeutic potential in a range of applications, including viral vaccines, protein replacement therapies, cancer immunotherapies, cellular reprogramming and genome editing. To achieve therapeutic effects, mRNA molecules have to reach specific target cells and produce sufficient proteins of interest.  Lipid nanoparticles (LNPs) are the leading nonviral technologies for the delivery of exogenous RNA to target cells in vivo. A major challenge to advance lipid nanoparticles (LNPs) for RNA therapeutics is the development of formulations that can be produced reliably across the various scales of drug development.


Seattle Genova is highly specialized in synthesizing top-quality mRNA and lipid nanoparticles for research and development applications, focusing on tailored production to meet your specific needs. We also offer a standard portfolio with optimized stability, solubility, and handling characteristics. 


LNPs are typically composed of glycerophospholipids, canonic lipids, sterol lipids, and PEGylated lipids that encapsulate oligonucleotides, which are contained within an aqueous phase.


Table 1: Commonly used mRNA delivery systems


Lipid Nanoparticle

Liposome

Solid Lipid Nanoparticle

Nanostructured Lipid Carrier

Lipid Shell

Monolayer

Bilayer

Surfactant

Surfactant

Internal Core

Reverse micelles

Aqueous

Solid lipids

Solid and liquid lipids

Cargo

Oligonucleotides

Hydrophobic and/or hydrophilic small molecules

Hydrophobic and/or hydrophilic small molecules

Hydrophobic and/or hydrophilic small molecules

Size

~20-100 nm

~50-1,000 nm

~40-1,000 nm

~40-1,000 nm


Generally, mRNA-LNP design is comprised of several elements: (1) mRNA sequence design and nucleotide modification choice, (2) Optimization of a LNP formulation to encapsulate and deliver mRNA and (3) long-term storage. Each one of these phases entails a plethora of choices and considerations to make. 


Workflow of mRNA Preparation:

1.Antigen design

2.Plasmid production

3.In vitro transcription

4.Characterization

 A, primary structure of mRNA

-Sequencing

-Mapping

-mRNA modification analysis

B, mRNA secondary structure

-CD

-Cryo-EM

-Secondary structure prediction

C, mRNA product analysis

-mRNA integrity and purity analysis

-analysis of mRNA capping efficiency

-Poly A tail length analysis

-Double-Stranded RNA Analysis


Procedures for the preparation of LNPs:

1.Design

-Lipid molar ratio

-Lipid:oligonucleotide weight ratio 

-Ionizable lipid nitrogen:oligonucleotide phosphate (N:P) molar ratio

-Lipid acid dissociation constant (lipid pK)

-Buffer composition, ionic strength, and pH

-Particle size and pharmacokinetics

-Routes of administration for LNPs


2.Preparation and mixing

-Mixing

-Extrusion

-Dialysis

-Filter-sterilize


3.Stability

-Physical stability

-Chemical stability 

-Biological stability


4.Storage

-Short-term storage at 4°C


CONTACT US

Thank you for your interest in our LNP Formulated RNA Production Service services. Please complete the form below and we will contact you shortly.

Fields indicated by an * are required.

Please fill in the first name
Please fill in the last name
Please fill in the email
Please fill in the company
Please fill in the phone
Please fill in the postal code
Please fill in the city
Please agree to the agreement.
0.100186s